• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即时检验在胃肠道癌症诊断中的应用:当前技术与未来方向

Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

作者信息

Huddy Jeremy R, Ni Melody Z, Markar Sheraz R, Hanna George B

机构信息

Jeremy R Huddy, Melody Z Ni, Sheraz R Markar, George B Hanna, Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, South Wharf Road, W2 1NY London, United Kingdom.

出版信息

World J Gastroenterol. 2015 Apr 14;21(14):4111-20. doi: 10.3748/wjg.v21.i14.4111.

DOI:10.3748/wjg.v21.i14.4111
PMID:25892860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4394071/
Abstract

Point-of-care (POC) tests enable rapid results and are well established in medical practice. Recent advances in analytical techniques have led to a new generation of POC devices that will alter gastrointestinal diagnostic pathways. This review aims to identify current and new technologies for the POC diagnosis of gastrointestinal cancer. A structured search of the Embase and Medline databases was performed. Papers reporting diagnostic tests for gastrointestinal cancer available as a POC device or containing a description of feasibility for POC application were included. Studies recovered were heterogeneous and therefore results are presented as a narrative review. Six diagnostic methods were identified (fecal occult blood, fecal proteins, volatile organic compounds, pyruvate kinase isoenzyme type M2, tumour markers and DNA analysis). Fecal occult blood testing has a reported sensitivity of 66%-85% and specificity greater than 95%. The others are at a range of development and clinical application. POC devices have a proven role in the diagnosis of gastrointestinal cancer. Barriers to their implementation exist and the transition from experimental to clinical medicine is currently slow. New technologies demonstrate potential to provide accurate POC tests and an ability to diagnose gastrointestinal cancer at an early stage with improved clinical outcome and survival.

摘要

即时检验(POC)能够快速得出结果,在医学实践中已得到广泛应用。分析技术的最新进展催生了新一代即时检验设备,这些设备将改变胃肠道疾病的诊断途径。本综述旨在确定用于胃肠道癌即时诊断的现有技术和新技术。我们对Embase和Medline数据库进行了结构化检索。纳入了报告可作为即时检验设备用于胃肠道癌诊断的测试,或包含即时检验应用可行性描述的论文。检索到的研究具有异质性,因此结果以叙述性综述的形式呈现。我们确定了六种诊断方法(粪便潜血、粪便蛋白质、挥发性有机化合物、丙酮酸激酶同工酶M2型、肿瘤标志物和DNA分析)。据报道,粪便潜血检测的灵敏度为66%-85%,特异性大于95%。其他方法则处于不同的研发和临床应用阶段。即时检验设备在胃肠道癌诊断中已被证明具有重要作用。其实施存在障碍,从实验医学向临床医学的转变目前较为缓慢。新技术显示出提供准确即时检验的潜力,以及在早期诊断胃肠道癌从而改善临床结局和生存率的能力。

相似文献

1
Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.即时检验在胃肠道癌症诊断中的应用:当前技术与未来方向
World J Gastroenterol. 2015 Apr 14;21(14):4111-20. doi: 10.3748/wjg.v21.i14.4111.
2
Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.肿瘤M2型丙酮酸激酶:一种胃肠道癌标志物。
Eur J Gastroenterol Hepatol. 2007 Mar;19(3):265-76. doi: 10.1097/MEG.0b013e3280102f78.
3
Metabolomics profile in gastrointestinal cancers: Update and future perspectives.胃肠癌的代谢组学特征:更新与未来展望。
World J Gastroenterol. 2020 May 28;26(20):2514-2532. doi: 10.3748/wjg.v26.i20.2514.
4
Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy.肿瘤M2型丙酮酸激酶:一种肿瘤标志物及其在胃肠道恶性肿瘤中的临床应用
Expert Rev Mol Diagn. 2008 Sep;8(5):579-85. doi: 10.1586/14737159.8.5.579.
5
The impact of digital technologies on point-of-care diagnostics in resource-limited settings.数字技术对资源有限环境下即时诊断的影响。
Expert Rev Mol Diagn. 2018 Apr;18(4):385-397. doi: 10.1080/14737159.2018.1460205. Epub 2018 Apr 10.
6
Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy.肿瘤M2型丙酮酸激酶(tumor M2-PK)作为胃肠道恶性肿瘤生物标志物的现状
Ann Surg Oncol. 2007 Oct;14(10):2714-20. doi: 10.1245/s10434-007-9481-x. Epub 2007 Jun 30.
7
Advances in point-of-care technologies for molecular diagnostics.即时检测技术在分子诊断学中的新进展。
Biosens Bioelectron. 2017 Dec 15;98:494-506. doi: 10.1016/j.bios.2017.07.024. Epub 2017 Jul 11.
8
Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.胃肠道肿瘤的分子检测:早期检测与筛查的创新
Gastroenterol Clin North Am. 2016 Sep;45(3):529-42. doi: 10.1016/j.gtc.2016.04.009.
9
Incremental advances in excremental cancer detection tests.粪便癌症检测试验的渐进式进展。
J Natl Cancer Inst. 2009 Sep 16;101(18):1225-7. doi: 10.1093/jnci/djp273. Epub 2009 Aug 21.
10
Innovations in point-of-care testing for enhanced United States disaster caches.用于增强美国灾难储备的即时检测创新。
Am J Disaster Med. 2013 Summer;8(3):181-204. doi: 10.5055/ajdm.2013.0125.

引用本文的文献

1
Microfluidic Gastrointestinal Cell Culture Technologies-Improvements in the Past Decade.微流控胃肠道细胞培养技术-过去十年的改进。
Biosensors (Basel). 2024 Sep 19;14(9):449. doi: 10.3390/bios14090449.
2
Qualitative analysis of stakeholder interviews to identify the barriers and facilitators to the adoption of point-of-care diagnostic tests in the UK.对利益相关者访谈进行定性分析,以确定在英国采用即时诊断检测的障碍和促进因素。
BMJ Open. 2021 Apr 13;11(4):e042944. doi: 10.1136/bmjopen-2020-042944.
3
Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?用于非侵入性检测结直肠癌的生物标志物:DNA、RNA还是蛋白质?
World J Gastrointest Oncol. 2020 Feb 15;12(2):124-148. doi: 10.4251/wjgo.v12.i2.124.
4
Emerging Designs of Electronic Devices in Biomedicine.生物医学中电子设备的新兴设计。
Micromachines (Basel). 2020 Jan 22;11(2):123. doi: 10.3390/mi11020123.
5
Faecal Occult Blood Point-of-Care Tests.粪便潜血即时检验
J Gastrointest Cancer. 2018 Dec;49(4):402-405. doi: 10.1007/s12029-018-0169-1.
6
Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.不可切除或转移性食管癌症的治疗:当前证据和趋势。
Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):235-249. doi: 10.1038/nrgastro.2017.162. Epub 2017 Dec 13.
7
Omics-based molecular techniques in oral pathology centred cancer: prospect and challenges in Africa.基于组学的口腔病理学中心癌症分子技术:非洲的前景与挑战
Cancer Cell Int. 2017 Jun 5;17:61. doi: 10.1186/s12935-017-0432-8. eCollection 2017.
8
Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.对ABC转运蛋白ABCB1/MDR/ P-糖蛋白、ABCC2/MRP2和ABCG2/BCRP在结直肠癌病理生理学中的新认识。
World J Gastroenterol. 2015 Nov 7;21(41):11862-76. doi: 10.3748/wjg.v21.i41.11862.
9
Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives.用于结直肠癌筛查的粪便DNA检测:分子靶点与展望。
World J Gastrointest Oncol. 2015 Oct 15;7(10):178-83. doi: 10.4251/wjgo.v7.i10.178.

本文引用的文献

1
A stool DNA test (Cologuard) for colorectal cancer screening.用于结直肠癌筛查的粪便DNA检测(Cologuard)。
Med Lett Drugs Ther. 2014 Oct 13;56(1453):100-1.
2
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.粪便免疫化学检测用于结直肠癌的准确性:系统评价和荟萃分析。
Ann Intern Med. 2014 Feb 4;160(3):171. doi: 10.7326/M13-1484.
3
Multitarget stool DNA testing for colorectal-cancer screening.多靶点粪便 DNA 检测用于结直肠癌筛查。
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.
4
Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.循环肿瘤细胞:分离与分析的进展及其在临床应用中的挑战。
Pharmacol Ther. 2014 Feb;141(2):209-21. doi: 10.1016/j.pharmthera.2013.10.004. Epub 2013 Oct 14.
5
Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.无症状个体中,柔性乙状结肠镜检查与粪便潜血检测用于结直肠癌筛查的比较。
Cochrane Database Syst Rev. 2013 Oct 1;2013(9):CD009259. doi: 10.1002/14651858.CD009259.pub2.
6
DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.DNA 甲基化生物标志物作为结直肠癌的诊断和预后工具。
J Mol Med (Berl). 2013 Nov;91(11):1249-56. doi: 10.1007/s00109-013-1088-z. Epub 2013 Sep 21.
7
Simultaneous DNA amplification and detection using a pH-sensing semiconductor system.利用 pH 感应半导体系统进行 DNA 的同步扩增和检测。
Nat Methods. 2013 Jul;10(7):641-6. doi: 10.1038/nmeth.2520. Epub 2013 Jun 9.
8
A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detection.一种用于结直肠癌基因突变检测的新型全自动分子诊断系统(AMDS)。
PLoS One. 2013 May 9;8(5):e62989. doi: 10.1371/journal.pone.0062989. Print 2013.
9
Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.采用选择离子流管质谱分析法分析呼出气中的挥发性有机化合物,以进行食管-胃交界部癌症的特征分析。
Anal Chem. 2013 Jun 18;85(12):6121-8. doi: 10.1021/ac4010309. Epub 2013 May 29.
10
A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions.基于纳米材料的呼吸测试,用于区分胃癌与良性胃部疾病。
Br J Cancer. 2013 Mar 5;108(4):941-50. doi: 10.1038/bjc.2013.44.